𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase II study of mitomycin-C, vincristine, and bleomycin in advanced squamous cell carcinoma of the uterine cervix

✍ Scribed by Laurence H. Baker; Michael I. Opipari; Ronald M. Izbicki


Publisher
John Wiley and Sons
Year
1976
Tongue
English
Weight
250 KB
Volume
38
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Aberrant FHIT transcripts in squamous ce
✍ Kiyoshi Yoshino; Takayuki Enomoto; Takafumi Nakamura; Ryuichi Nakashima; Hiroko πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 French βš– 182 KB πŸ‘ 1 views

The fragile histidine triad (FHIT) tumor suppressor gene at 3p14.2 has abnormalities in several types of human cancers. To investigate the potential role of FHIT in cervical cancer, which exhibits frequent loss of heterozygosity of 3p, we have examined primary cervical cancer samples from 28 patient

Phase II study of carboplatin and liposo
✍ Claire F. Verschraegen; John J. Kavanagh; Evelyne Loyer; Diane Bodurka-Bevers; A πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 85 KB πŸ‘ 1 views

## BACKGROUND. The activity of the combination of carboplatin and liposomal doxorubicin was tested in a Phase II study of patients with recurrent cervical carcinoma. ## METHODS. The combination of carboplatin (area under the concentration curve [AUC], 5) and liposomal doxorubicin (Doxil; starti